Patents by Inventor Olivier Lambert

Olivier Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
    Patent number: 8367685
    Abstract: Stable pharmaceutical compositions include the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof:
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: February 5, 2013
    Assignee: Actelion Pharmaceuticals, Ltd.
    Inventors: Charles Tokunbo Adesuyi, Lovelace Holman, Olivier Lambert, Bruce Hamilton Lithgow
  • Pharmaceutical composition comprising cyclic somatostatin analogues
    Patent number: 8299209
    Abstract: Pharmaceutical compositions comprising a somastatin analogue in the form of a liquid formulation for parenteral administration are disclosed.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: October 30, 2012
    Assignee: Novartis AG
    Inventors: Olivier Lambert, Katrin Moser
  • MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES
    Publication number: 20120214749
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Application
    Filed: April 26, 2012
    Publication date: August 23, 2012
    Applicant: NOVARTIS AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • Microparticles comprising somatostatin analogues
    Patent number: 8188037
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: May 29, 2012
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • PHARMACEUTICAL MICROPARTICLES
    Publication number: 20120107408
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 3, 2012
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Pharmaceutical microparticles
    Patent number: 8110224
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: February 7, 2012
    Assignee: Novartis AG
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
    Publication number: 20110301100
    Abstract: A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent.
    Type: Application
    Filed: August 15, 2011
    Publication date: December 8, 2011
    Applicant: NOVARTIS AG
    Inventor: Olivier Lambert
  • MICROPARTICLES COMPRISING SOMATOSTATIN ANALOGUES
    Publication number: 20100272809
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Application
    Filed: June 8, 2010
    Publication date: October 28, 2010
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100215734
    Abstract: The present invention provides a pharmaceutical composition in solid form comprising a poorly water soluble drug, a solubilizing component, and a surfactant which is semisolid or solid. The poorly soluble drug may e.g. be a cyclosporin or a macrolide.
    Type: Application
    Filed: May 5, 2010
    Publication date: August 26, 2010
    Inventors: Michael Ambühl, Barbara Haeberlin, Barbara Lückel, Armin Meinzer, Olivier Lambert, Laurent Marchal
  • Microparticles comprising somatostatin analogues
    Patent number: 7759308
    Abstract: Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: July 20, 2010
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Michael Ausborn, Olivier Lambert, Marc Riemenschnitter
  • Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
    Publication number: 20100178344
    Abstract: The present invention relates to improved microparticles comprising a somatostatin analogue, a process of making said microparticles and to pharmaceutical compositions comprising the same.
    Type: Application
    Filed: May 23, 2008
    Publication date: July 15, 2010
    Applicant: NOVARTIS AG
    Inventors: Olivier Lambert, Marc Riemenschnitter, Vitomir Vucenovic
  • ORGANIC COMPOUNDS
    Publication number: 20100029550
    Abstract: A pharmaceutical composition for parenteral administration of a somatostatin analogue salt of aspartate, e.g. mono- or diaspartate, lactate, succinate, e.g. mono- or disuccinate, acetate, glutamate, e.g. mono- or diglutamate or citrate and water forming a gelling depot system after injection in contact with the body fluid.
    Type: Application
    Filed: December 20, 2005
    Publication date: February 4, 2010
    Inventor: Olivier Lambert
  • Stable pharmaceutical compositions comprising a pyrimidine-sulfamide
    Publication number: 20100004274
    Abstract: Stable pharmaceutical compositions include the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof:
    Type: Application
    Filed: February 18, 2009
    Publication date: January 7, 2010
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Charles Tokunbo Adesuyi, Lovelace Holman, Olivier Lambert, Bruce Hamilton Lithgow
  • ORGANIC COMPOUNDS
    Publication number: 20090312441
    Abstract: A solid pharmaceutical composition comprising a poorly water soluble drug, a polymer which is solid at room temperature, and a disintegrant in an amount of less than 10% by weight, wherein the amounts by weight are based on the total weight of the composition.
    Type: Application
    Filed: December 20, 2005
    Publication date: December 17, 2009
    Applicant: NOVARTIS AG
    Inventors: Michael Ambühl, Dieter Becker, Olivier Lambert, Barbara Lückel
  • PHARMACEUTICAL COMPOSITION COMPRISING CYCLIC SOMATOSTATIN ANALOGUES
    Publication number: 20090137462
    Abstract: The present invention describes parenteral pharmaceutical compositions comprising a somatostatin analogue and novel somatostatin analogues.
    Type: Application
    Filed: January 26, 2009
    Publication date: May 28, 2009
    Inventors: Olivier Lambert, Katrin Moser
  • Pharmaceutical microparticles
    Publication number: 20080279955
    Abstract: Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.
    Type: Application
    Filed: July 17, 2008
    Publication date: November 13, 2008
    Inventors: Michael Ausborn, Olivier Lambert, Oskar Nagele
  • Stable Pharmaceutical Compositions Comprising a Pyrimidine - Sulfamide
    Publication number: 20080233188
    Abstract: The invention relates to stable pharmaceutical compositions comprising the compound of the below formula, or pharmaceutically acceptable salts, solvates, hydrates or morphological forms thereof.
    Type: Application
    Filed: September 11, 2006
    Publication date: September 25, 2008
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Charles Tokunbo Adesuyi, Lovelace Holman, Olivier Lambert, Bruce Hamilton Lithgow
  • Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
    Publication number: 20080213330
    Abstract: A liquid pharmaceutical composition comprising a biodegradable polymer, polyethylene glycol having a molecular weight of less than 600 Daltons, a pharmaceutically active agent and less than 0.5% of an biologically acceptable organic solvent.
    Type: Application
    Filed: June 8, 2005
    Publication date: September 4, 2008
    Inventor: Olivier Lambert
  • Organic compounds
    Publication number: 20070122485
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: January 8, 2007
    Publication date: May 31, 2007
    Inventors: Holger Petersen, Olivier Lambert, Rolf Loeffler, Michael Ausborn, Jean-Daniel Bonny
  • Pharmaceutical composition comprising cyclic somatostatin analogues
    Publication number: 20070093412
    Abstract: The present invention describes parenteral pharmaceutical compositions comprising a somatostatin analogue and novel somatostatin analogues.
    Type: Application
    Filed: June 23, 2004
    Publication date: April 26, 2007
    Inventors: Olivier Lambert, Katrin Moser